(1997). The management of cancer patients: separate research experiences with gemcitabine HCl and DAB 389 IL-2 fusion protein: Based on scientific proceedings of an Eli Lilly and Company satellite symposium at the 8th European Conference on Clinical Oncology and Cancer Nursing in Paris, 29 October - 2 November 1995. Pergamon.
Chicago-Zitierstil (17. Ausg.)The Management of Cancer Patients: Separate Research Experiences with Gemcitabine HCl and DAB 389 IL-2 Fusion Protein: Based on Scientific Proceedings of an Eli Lilly and Company Satellite Symposium at the 8th European Conference on Clinical Oncology and Cancer Nursing in Paris, 29 October - 2 November 1995. Oxford [u.a.]: Pergamon, 1997.
MLA-Zitierstil (9. Ausg.)The Management of Cancer Patients: Separate Research Experiences with Gemcitabine HCl and DAB 389 IL-2 Fusion Protein: Based on Scientific Proceedings of an Eli Lilly and Company Satellite Symposium at the 8th European Conference on Clinical Oncology and Cancer Nursing in Paris, 29 October - 2 November 1995. Pergamon, 1997.